共 18 条
- [8] Therapeutic drug monitoring study on the switch from coformulated 600-mg efavirenz, tenofovir disoproxil fumarate, and emtricitabine to coformulated 400-mg efavirenz, tenofovir disoproxil fumarate, and lamivudine among HIV-positive patients with viral suppression [J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2021, 54 (05) : 944 - 951